Sarepta Therapeutics, Inc. (BVMF:S1RP34)

Sarepta Therapeutics Revenue

Sarepta Therapeutics had revenue of $399.36M USD in the quarter ending September 30, 2025, a decrease of -14.52%. This brings the company's revenue in the last twelve months to $2.41B, up 47.15% year-over-year. In the year 2024, Sarepta Therapeutics had annual revenue of $1.90B with 52.97% growth.

• Revenue (ttm): $2.41B
• Revenue Growth: +47.15%
• P/S Ratio: 0.78
• Revenue / Employee: $1.76M
• Employees: 1,372
• Market Cap: 9.99B BRL

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.90B	658.64M	52.97%
Dec 31, 2023	1.24B	310.32M	33.26%
Dec 31, 2022	933.01M	231.13M	32.93%
Dec 31, 2021	701.89M	161.79M	29.96%
Dec 31, 2020	540.10M	159.27M	41.82%